Clinical Trial Update: Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing safety and immunogenicity of malaria vaccines FP9 PP and MVA PP completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Malaria Falciparum

Drugs mentioned

• FP9 PP
• MVA PP

Snippet

Sponsor: European Vaccine Initiative | Conditions: Malaria, Falciparum, Malaria | Phase 1 | Status: COMPLETED